NO931527D0 - Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling - Google Patents

Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling

Info

Publication number
NO931527D0
NO931527D0 NO931527A NO931527A NO931527D0 NO 931527 D0 NO931527 D0 NO 931527D0 NO 931527 A NO931527 A NO 931527A NO 931527 A NO931527 A NO 931527A NO 931527 D0 NO931527 D0 NO 931527D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
preparations containing
medicinal preparations
cyclic imino
Prior art date
Application number
NO931527A
Other languages
English (en)
Other versions
NO931527L (no
Inventor
Guenter Linz
Volkhard Austel
Frank Himmelsbach
Johannes Weisenberger
Thomas Mueller
Helmut Pieper
Elke Seewaldt-Becker
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO931527D0 publication Critical patent/NO931527D0/no
Publication of NO931527L publication Critical patent/NO931527L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO93931527A 1992-04-28 1993-04-27 Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling NO931527L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4213931A DE4213931A1 (de) 1992-04-28 1992-04-28 Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO931527D0 true NO931527D0 (no) 1993-04-27
NO931527L NO931527L (no) 1993-10-29

Family

ID=6457642

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931527A NO931527L (no) 1992-04-28 1993-04-27 Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling

Country Status (14)

Country Link
US (1) US5489693A (no)
EP (1) EP0567968A1 (no)
JP (1) JPH0625159A (no)
KR (1) KR930021615A (no)
AU (1) AU659933B2 (no)
CA (1) CA2094964A1 (no)
DE (1) DE4213931A1 (no)
FI (1) FI931882A (no)
HU (1) HU9301223D0 (no)
IL (1) IL105518A0 (no)
MX (1) MX9302459A (no)
NO (1) NO931527L (no)
NZ (1) NZ247502A (no)
PL (1) PL298718A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018058A1 (en) * 1992-03-06 1993-09-16 G.D. Searle & Co. Peptides mimics useful as platelet aggregation inhibitors
JPH0616948A (ja) * 1992-04-16 1994-01-25 Mearthane Prod Corp 導電性及び半導電性ポリマー材
DE4241632A1 (de) * 1992-12-10 1994-06-16 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5721366A (en) * 1993-03-31 1998-02-24 G. D. Searle & Co Platelet aggregation inhibitors
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
AU6318896A (en) * 1995-07-06 1997-02-05 Japan Tobacco Inc. Benzamidoxime derivatives and medicinal use thereof
CA2333927A1 (en) 1998-04-01 1999-10-07 Dupont Pharmaceuticals Company Pyrimidines and triazines as integrin antagonists
WO2000029406A2 (en) 1998-11-18 2000-05-25 Du Pont Pharmaceuticals Company Novel isoxazoline fibrinogen receptor antagonists
US6319937B1 (en) 1998-11-18 2001-11-20 Dupont Pharmaceuticals Company Isoxazoline fibrinogen receptor antagonists
DE19936789A1 (de) * 1999-08-09 2001-03-01 Vectron Therapeutics Ag Neue Pyrrolidinole und ihre Verwendung für die Tumortherapie
US8222341B2 (en) 2009-03-17 2012-07-17 Mearthane Products Corporation Semi-conductive silicone polymers
CN102206178B (zh) * 2010-03-30 2013-04-10 上海源力生物技术有限公司 制备艾瑞昔布的方法
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2123288A (en) * 1982-07-16 1984-02-01 Wellcome Found Anti-thrombotic agent
AU602485B2 (en) * 1985-03-16 1990-10-18 Wellcome Foundation Limited, The Lipoxygenase and/or cyclooxygenase inhibitory compounds
DE3823299A1 (de) * 1988-07-07 1990-01-11 Schering Ag Substituierte phenyl-pyrrolidin-2-one, -oxazolidin-2-one und -imidazolidin-2-one, ihre herstellung sowie verwendung in arzneimitteln
JPH02247166A (ja) * 1989-03-17 1990-10-02 Taisho Pharmaceut Co Ltd 3―ピロリン―2―オン誘導体
US5026861A (en) * 1989-07-17 1991-06-25 Merrell Dow Pharmaceuticals Substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones
AU632963B2 (en) * 1990-09-07 1993-01-14 Mitsui Toatsu Chemicals Inc. 3,4-trans-4-ethyl-1-(substituted phenyl)-3-(substituted phenyl)pyrrolidin-2-ones, method for preparing the same, and herbicidal compositions containing the same as herbicidally active ingredients
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4107857A1 (de) * 1991-03-12 1992-09-17 Thomae Gmbh Dr K Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4127404A1 (de) * 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0567968A1 (de) 1993-11-03
US5489693A (en) 1996-02-06
HU9301223D0 (en) 1993-07-28
JPH0625159A (ja) 1994-02-01
IL105518A0 (en) 1993-08-18
AU3822393A (en) 1993-11-04
NO931527L (no) 1993-10-29
FI931882A (fi) 1993-10-29
PL298718A1 (en) 1994-01-24
KR930021615A (ko) 1993-11-22
CA2094964A1 (en) 1993-10-29
FI931882A0 (fi) 1993-04-27
NZ247502A (en) 1995-09-26
AU659933B2 (en) 1995-06-01
MX9302459A (es) 1994-06-30
DE4213931A1 (de) 1993-11-04

Similar Documents

Publication Publication Date Title
DK539789D0 (da) Carbostyrilderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant carbostyrilderivat
NO924027D0 (no) Heterobiarylderivater, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling
NO930517D0 (no) Benzimidazolylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
NO933248D0 (no) Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsm}te for deres fremstilling
NO893678L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
EE9400455A (et) Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
NO932120D0 (no) Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
NO931527D0 (no) Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling
DK130389A (da) Catecholderivater og farmaceutiske praeparater omfatende samme
DK162491D0 (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
DK162892C (da) 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
NO931342D0 (no) Benzimidazoler, medisinske preparater inneholdende disse,og fremgangsmaate for deres fremstilling
NO932636L (no) Benzimidazoler, medikamenter inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling
DK304090A (da) Glycerolderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
DK269289D0 (da) Cyklopentanderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
NO922358D0 (no) Tert.-butylfenyl-1-amino-4-hydroksybutanderivater, fremgangsmaate ved deres fremstilling og farmasoeytiske preparaterinneholdende forbindelsene
DK449989A (da) Quinolinderivater, deres fremstilling og laegemidler indeholdende disse derivater
NO305959B1 (no) Tiosubstituerte cykliske fosfonatforbindelser, anvendelser derav, og farmasoeytiske preparater inneholdende slike forbindelser
DK155692A (da) Benzofuranylimidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse
DK299590D0 (da) Phospholipidderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK300989D0 (da) Alaninderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne forbindelser
NO305792B1 (no) Substituerte benzensulfonylureaer, deres anvendelse for fremstilling av farmas°ytiske preparater og medikamenter inneholdende disse
DK276690D0 (da) Selenophenderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
NO924563L (no) Benzokinoksaliner, fremgangsmaate for deres fremstilling og farmasoeytiske preparater inneholdende de nevnte forbindelser